Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a specific N-terminal pyroglutamate amyloid beta (A??) epitope. This antibody is designed for use in research focused on early-stage Alzheimer's disease, providing a critical tool for studies aimed at understanding and potentially intervening in the disease's pathogenesis.
Donanemab (LY3002813) is a humanized IgG1 monoclonal antibody that targets a specific N-terminal pyroglutamate amyloid beta (A??) epitope. This antibody is designed for use in research focused on early-stage Alzheimer's disease, providing a critical tool for studies aimed at understanding and potentially intervening in the disease's pathogenesis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
